Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer

In recent years, diabetes-associated breast cancer has become a significant clinical challenge. Diabetes is not only a risk factor for breast cancer but also worsens its prognosis. Patients with diabetes usually show hyperglycemia and hyperinsulinemia, which are accompanied by different glucose, pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Shum, Hang Chee Erin, Wu, Ke, Vadgama, Jaydutt, Wu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861470/
https://www.ncbi.nlm.nih.gov/pubmed/36675817
http://dx.doi.org/10.3390/jpm13010157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861470/
https://www.ncbi.nlm.nih.gov/pubmed/36675817
http://dx.doi.org/10.3390/jpm13010157

Ejemplares similares